Perspectives of Indian Gastroenterologists and Hepatologists on Nonalcoholic Fatty Liver Disease Diagnosis and Management: Insights From the Nationwide Web-Based Cross-Sectional DRIVE Survey
This large, nationwide survey highlights that NAFLD and NASH constitute a major part of gastroenterology and hepatology practice in India. Although transient elastography and pharmacological agents such as saroglitazar and vitamin E are widely used, considerable heterogeneity exists in diagnostic and management approaches. The lack of patient awareness and effective treatment options remain the major hurdles in managing NAFLD and NASH. These findings underscore the need for the wider implementation of existing India-specific consensus recommendations, continued physician education, and future research focusing on tailored interventions in the management of NAFLD and NASH for the Indian population.
Authors
- Yogesh Garje
- Suyog Mehta (ORCID: https://orcid.org/0000-0001-7553-4128)
- Neeraj Markandeywar
- Chintan Khandhedia (ORCID: https://orcid.org/0009-0004-5632-7181)
- Shruti Dharmadhikari (ORCID: https://orcid.org/0000-0002-2249-2662)
- Shagupta Shaikh
- Amey Mane
- Ashish Kumar
- Anil Arora
Institutions
- Sir Ganga Ram Hospital (IN)
- Sun Pharma (India) (IN)
- Sun Pharma Advanced Research (India) (IN)
Publication Details
- Journal
- Interactive Journal of Medical Research
- Published
- 2026-03-02
- DOI
- https://doi.org/10.2196/75138
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00